{
 "Susceptible": {
 "Drug": {
 "Amikacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       75,       25 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Aztreonam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       75,       25 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       25,       75 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Cefepime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       75,       25 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 66.66667, 33.33333 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 33.33333, 66.66667 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime avibactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       75,       25 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftolozane tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 66.66667, 33.33333 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 33.33333, 66.66667 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftriaxone": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       50,       50 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Doripenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       75,       25 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Imipenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       75,       25 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Levofloxacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 66.66667, 33.33333 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 33.33333, 66.66667 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Meropenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       75,       25 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [ 66.66667, 33.33333 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 33.33333, 66.66667 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       75,       25 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [ 8.695652, 8.695652, 8.695652, 6.521739, 8.695652, 6.521739, 4.347826, 8.695652, 8.695652, 6.521739, 8.695652, 6.521739, 8.695652 ],
"weight":    0.575,
"backgroundColor": [ "#a6cee3", "#ccebc5", "#fb9a99", "#fdbf6f", "#e7298a", "#e78ac3", "#ff7f00", "#e41a1c", "#b15928", "#8dd3c7", "#bebada", "#b3de69", "#fccde5" ] 
},
"Intermediate": {
 "Drug": {
 "Ceftaroline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       50,       50 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
} 
},
"percentage":      100,
"weight":    0.025,
"backgroundColor": "#d95f02" 
},
"Resistant": {
 "Drug": {
 "Amikacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Amoxycillin clavulanate": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       80,       20 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       40,       60 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ampicillin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female", "Male" ],
"percentage": [       80,       20 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       40,       60 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Aztreonam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Cefepime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftaroline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 66.66667, 33.33333 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftazidime avibactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftolozane tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Ceftriaxone": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [ 66.66667, 33.33333 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Doripenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Imipenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Levofloxacin": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Meropenem": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Piperacillin tazobactam": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "19 to 64 Years", "65 to 84 Years" ],
"percentage": [       50,       50 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
},
"Tigecycline": {
 "State": {
 "State": [ "N/A" ],
"percentage": [      100 ] 
},
"Gender": {
 "Gender": [ "Female" ],
"percentage": [      100 ] 
},
"Age.Group": {
 "Age.Group": [ "65 to 84 Years" ],
"percentage": [      100 ] 
},
"Speciality": {
 "Speciality": [ "None Given" ],
"percentage": [      100 ] 
},
"Source": {
 "Source": [ "GU: Urine" ],
"percentage": [      100 ] 
},
"In...Out.Patient": {
 "In...Out.Patient": [ "Other" ],
"percentage": [      100 ] 
} 
} 
},
"percentage": [    3.125,   15.625,   15.625,    3.125,    3.125,    9.375,     6.25,    3.125,     6.25,    9.375,    3.125,    3.125,     6.25,    3.125,     6.25,    3.125 ],
"weight":      0.4,
"backgroundColor": [ "#a6cee3", "#1f78b4", "#b2df8a", "#ccebc5", "#fb9a99", "#d95f02", "#fdbf6f", "#e7298a", "#e78ac3", "#ff7f00", "#e41a1c", "#b15928", "#8dd3c7", "#bebada", "#b3de69", "#fccde5" ] 
} 
}
